BC
ACHN

Boxer Capital’s Achillion Pharmaceuticals ACHN Stock Holding History

Boxer Capital’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,000,000
Closed -$18.2M – 68
2019
Q4 		$18.2M Buy
3,000,000
+1,000,000
+50% +$5.79M 1.03% 27
2019
Q3 		$7.2M Buy
+2,000,000
New +$7.71M 0.52% 36

Boxer Capital's ACHN Position: Q1 2020 in Review

Boxer Capital sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 3,000,000 shares — an estimated $18.2M sold.

Boxer Capital first reported a position in ACHN in Q3 2019 and held it in 2 quarters. The position peaked at $18.2M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Boxer Capital reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Boxer Capital sold 3,000,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $18.2M.
  • Boxer Capital first reported a position in Achillion Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Boxer Capital's Achillion Pharmaceuticals position peaked at $18.2M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Boxer Capital's 13F filing for Q1 2020, filed 15 May 2020.